The Phase 2 trial enrolled 46 patients with advanced breast cancer who were treated with a combination of the drug, called bavituximab, and chemotherapy drugs paclitaxel and carboplatin. The trial found that, after a treatment period of about six months, 34 patients achieved an “objective tumor response,” meaning their tumors shrank at least 30 percent. Four patients, [...]
Emily Dowling, of the U.S. National Cancer Institute, and colleagues studied findings from over 295,000 interviews in the National Health Interview Survey from the last few years. Of those interviews, 410 were with adult survivors of childhood cancer. The researchers found that childhood cancer survivors were more likely than other adults to say their health is only fair or [...]
Pancreatic cancer is considered one of the most deadly of cancers. The statistics are grim, as 95 percent of patients diagnosed with pancreatic cancer do not survive, and 50 percent of patients die within six months after the cancer is diagnosed. There might be some hope in an allergy medication that has been around for 40 years. According [...]